MusclePharm Corporation (MSLP)
$0.0002
Rating:
Recommendation:
-
| Symbol | MSLP |
|---|---|
| Price | $0.0002 |
| Beta | -0.052 |
| Volume Avg. | 0.01M |
| Market Cap | - |
| Shares () | - |
| 52 Week Range | 2.0E-4-0.59 |
| 1y Target Est | - |
| DCF Unlevered | MSLP DCF -> | |
|---|---|---|
| DCF Levered | MSLP LDCF -> | |
| ROE | 60.99% | Strong Buy |
| ROA | -160.82% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | -131.47% | Sell |
| P/E | -0 | Neutral |
| P/B | -0 | Neutral |
Latest MSLP news
About
Download (Excel)MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada. On December 15, 2022, MusclePharm Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Nevada.